No Change in New Patient Visit Volume During Year 1 of the ACA
Increased insurance coverage under the Affordable Care Act not only did not cause a sharp increase in new patients, but there has not been any change in how sick patients were who sought care, according to a report from athenahealth and the Robert Wood Johnson Foundation.
MRI For Low Back Pain More Costly Than Physical Therapy
A study of people who needed additional care for their low back pain, found that the ones sent first for MRIs were more likely to have surgery or injections, see a specialist, or visit an emergency room than those who were first sent to physical therapists.
Generic Drug Makers Challenge FDA Requirement
The pharmaceutical industry mounted a new challenge to a federal plan that would require generic drug companies to take the initiative to update their labels to warn consumers whenever health risks were discovered.
The Downsides to Healthcare Price Transparency
Last year, more than half of working Americans reportedly checked prices for the health services they required. Healthcare providers and policy makers are scrambling to meet consumer demand for accurate pricing, and it’s not easy.
Managed Care Minute: March 28, 2015
A one-minute look at managed care news during the week of March 23, 2015, including the 5-year anniversary of the Affordable Care Act and another step toward value-based payments.
Voters Prefer Federal Exchange to State-Run Ones
Although the Supreme Court’s decision on King v. Burwell
could remove subsidies from the federal marketplace, Americans prefer HealthCare.gov over the state-run exchanges, according to poll results from right-wing advocacy group Foundation for Government Accountability.
Hypertension Deaths Up, CDC Finds
The overall death rate from high blood pressure in the United States has increased 23% since 2000, even as the death rate from all other causes has dropped 21%, health officials reported.
Aledade Puts Tools for Success in the Hands of Physician-Led ACOs
When Aledade launched in 2014, founder Farzad Mostashari, MD, former national coordinator for health information technology (IT), was spending about half the time talking to doctors not about his new company, but about value-based payments and what accountable care organizations were.
Why Pharma Is Investing in Rare Diseases
As patents on some of the most lucrative medicines began to expire, many companies shifted money to rare-disease drugs, knowing that those medicines cost less to develop and will face limited competition.
Creating a Global Cancer Resource
The Global Cancer Project Map is an interactive online database that allows users to search for cancer experts and research projects by country and by cancer type, and then to initiate contact with project principal investigators and program directors.
San Francisco Close to Implementing Drug Take-Back Program
San Francisco has taken a big step toward becoming the first major US city to require drug makers to fund and administer a citywide take-back program in which consumers can bring unused and unexpired medicines to drop-off destinations for disposal.
Melanoma Trial Halted Early; Keytruda Betters Yervoy
Currently, Keytruda is approved for patients with advanced melanoma previously treated with Yervoy and, in some patients, another type of drug as well. That second- and third-line status limits the number of patients eligible for the drug.
Driving Precision Medicine With Exceptional Responders
The NCI wants to encourage clinical trial investigators to review data from their completed clinical trials and treating oncologists to look back in their patient records to identify potential cases of exceptional responses and submit them for consideration in the initiative.
Health Plan Cancellations Remain Uncommon Despite Concerns
With the Affordable Care Act’s requirement that most nongroup health insurance plans offer minimum coverage standards, concerns arose about plan cancellations affecting those who already had insurance coverage. However, recent data found cancellations were uncommon.